C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells
Authors:
- Quanmin NieQNQuanmin Nie
- Jin LanJLJin Lan
- Jianwei GeJGJianwei Ge
- Yongming QiuYQYongming Qiu
- Qing MaoQMQing Mao
- 1 November 2013
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 441 (1) , 186-190
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Science and Technology Committee (13XD1402600)
- Shanghai Government (0952nm03900, BXJ201024)
- Shanghai Jiao Tong University School of Medicine
This publication has 32 references indexed in Scilit:
- MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastomaCancer Genetics, 2013
- Myc proteins in brain tumor development and maintenanceUpsala Journal of Medical Sciences, 2012
- Reviewing once more the c-myc and Ras collaborationCell Cycle, 2011
- Myc-Induced MicroRNAs Integrate Myc-Mediated Cell Proliferation and Cell FateCancer Research, 2010
- c-Myc Is Required for Maintenance of Glioma Cancer Stem CellsPLOS ONE, 2008
- MYC stimulates EZH2 expression by repression of its negative regulator miR-26aBlood, 2008
- Promoter-binding and repression of PDGFRB by c-Myc are separable activitiesNucleic Acids Research, 2004
- Function of the c-Myc Oncogenic Transcription FactorExperimental Cell Research, 1999
- Amplification of C-MYC as the Origin of the Homogeneous Staining Region in Ovarian Carcinoma Detected by Micro-FISHCancer Genetics and Cytogenetics, 1999
- Amplification and expression of the c-myc oncogene in human lung cancer cell linesNature, 1983